GlassScriptPhysician profile
Mark S Humayun
NPI 1548322381
$45,104.93
in general payments reported to CMS, 2019-2025
12 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,127 · 2021: $5,133 · 2022: $8,167 · 2023: $5,507 · 2024: $9,554 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $3,297 · Food and Beverage: $2,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Travel and Lodging | $3,297.23 |
| Food and Beverage | $2,769.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $40,215.24 | 2019-2025 | Lensx |
| Alcon Vision LLC | $2,858.58 | 2019-2025 | Constellation, Hydrus Microstent, Ngenuity |
| Bausch & Lomb Americas INC. | $858.26 | 2022-2025 | Stellaris, Miebo |
| Regeneron Pharmaceuticals, INC. | $292.30 | 2021-2024 | Eylea Hd, Eylea |
| Cortigent INC | $175.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $173.71 | 2019-2020 | |
| Genentech USA, INC. | $148.02 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.92 | 2019 | |
| Alimera Sciences, INC. | $127.07 | 2024 | Iluvien, Yutiq |
| Neurotech Pharmaceuticals, INC. | $44.44 | 2025 | |
| Genentech, INC. | $33.18 | 2019-2020 | |
| Abbvie INC. | $32.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Humayun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.